Antibiotic prevention with Levofloxacin in children with Acute Lymphoblastic Leukemia

Phase 3

Recruiting

• Conditions: Acute lymphoblastic leukemia; C04.557.337.428.600

• Registration Number: RBR-9z76pk4
• Lead Sponsor: Hospital de Clínicas de Porto Alegre

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2022-11-16
• Last Update Posted: 29 May 2023
• Study Completion: 2026-01-01

Recruitment & Eligibility

• Status: Recruiting
• Sex: Not specified
• Target Recruitment: Not specified

Inclusion Criteria

Patients with an initial diagnosis of Acute Lymphoblastic Leukemia; age from 1 year to 18 years.

Exclusion Criteria

Children with clinically or microbiologically documented infection before initiation of induction or with fever before induction therapy that required prolonged antibiotic therapy (more than 5 days); history of allergy to the use of quinolones; history of chronic arthritis being treated; patients who developed febrile neutropenia within the first 7 days of induction.

Study & Design

• Study Type: Intervention
• Study Design: Not specified